F.L. Putnam Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.83M Sell
14,882
-337
-2% -$189K 0.09% 168
2026
Q1
$8.55M Sell
15,219
-201
-1% -$129K 0.13% 136
2025
Q4
$10.4M Sell
15,420
-56
-0.4% -$38.1K 0.15% 118
2025
Q3
$9.89M Sell
15,476
-233
-1% -$141K 0.15% 121
2025
Q2
$8.43M Sell
15,709
-526
-3% -$252K 0.14% 135
2025
Q1
$6.82M Sell
16,235
-359
-2% -$156K 0.13% 134
2024
Q4
$6.86M Sell
16,594
-177
-1% -$77.6K 0.13% 136
2024
Q3
$8.47M Sell
16,771
-1,120
-6% -$544K 0.15% 126
2024
Q2
$8.72M Sell
17,891
-212
-1% -$106K 0.16% 123
2024
Q1
$9.77M Buy
18,103
+56
+0.3% +$30.6K 0.21% 99
2023
Q4
$10M Sell
18,047
-93
-0.5% -$43.7K 0.24% 95
2023
Q3
$7.93M Buy
18,140
+10,468
+136% +$5.22M 0.22% 98
2023
Q2
$3.85M Sell
7,672
-45
-0.6% -$21.6K 0.1% 157
2023
Q1
$3.86M Buy
7,717
+137
+2% +$65.6K 0.13% 139
2022
Q4
$3.09M Sell
7,580
-308
-4% -$120K 0.11% 138
2022
Q3
$2.57M Sell
7,888
-40
-0.5% -$14.7K 0.1% 148
2022
Q2
$2.78M Sell
7,928
-55
-0.7% -$22.4K 0.1% 149
2022
Q1
$4.37M Sell
7,983
-183
-2% -$96.3K 0.14% 129
2021
Q4
$5.38M Sell
8,166
-115
-1% -$72.2K 0.16% 113
2021
Q3
$5.15M Sell
8,281
-6
-0.1% -$4.03K 0.17% 111
2021
Q2
$5.23M Buy
8,287
+1,182
+17% +$653K 0.18% 108
2021
Q1
$3.48M Sell
7,105
-56
-0.8% -$28.1K 0.15% 120
2020
Q4
$3.58M Hold
7,161
0.17% 108
2020
Q3
$2.81M Sell
7,161
-315
-4% -$116K 0.15% 105
2020
Q2
$2.47M Buy
7,476
+128
+2% +$37.1K 0.15% 107
2020
Q1
$1.78M Sell
7,348
-526
-7% -$137K 0.14% 117
2019
Q4
$2.06M Buy
7,874
+36
+0.5% +$9.49K 0.13% 125
2019
Q3
$2.13M Buy
7,838
+97
+1% +$27K 0.15% 115
2019
Q2
$2.13M Sell
7,741
-15
-0.2% -$3.7K 0.17% 106
2019
Q1
$1.73M Hold
7,756
0.15% 107
2018
Q4
$1.44M Buy
7,756
+2,907
+60% +$596K 0.16% 109
2018
Q3
$1.21M Hold
4,849
0.11% 131
2018
Q2
$1.06M Hold
4,849
0.1% 135
2018
Q1
$928K Hold
4,849
0.08% 142
2017
Q4
$758K Hold
4,849
0.07% 152
2017
Q3
$754K Buy
+4,849
New +$767K 0.07% 154
2017
Q1
$836K Hold
5,410
0.09% 142
2016
Q4
$634K Sell
5,410
-50
-0.9% -$5.71K 0.07% 138
2016
Q3
$616K Sell
5,460
-65
-1% -$6.85K 0.07% 134
2016
Q2
$513K Hold
5,525
0.06% 129
2016
Q1
$433K Buy
5,525
+135
+3% +$9.72K 0.05% 130
2015
Q4
$393K Sell
5,390
-450
-8% -$32.1K 0.05% 137
2015
Q3
$434K Sell
5,840
-120
-2% -$8.6K 0.05% 136
2015
Q2
$382K Sell
5,960
-878
-13% -$60.8K 0.04% 146
2015
Q1
$528K Sell
6,838
-120
-2% -$9.34K 0.06% 133
2014
Q4
$516K Sell
6,958
-130
-2% -$9.12K 0.06% 141
2014
Q3
$418K Buy
7,088
+50
+0.7% +$3.16K 0.05% 150
2014
Q2
$470K Hold
7,038
0.05% 153
2014
Q1
$427K Buy
7,038
+386
+6% +$23K 0.05% 161
2013
Q4
$354K Sell
6,652
-500
-7% -$26.3K 0.04% 167
2013
Q3
$356K Sell
7,152
-400
-5% -$19.2K 0.05% 167
2013
Q2
$339K Buy
+7,552
New +$330K 0.05% 159

Other funds holding IDXX

F.L. Putnam Investment Management's IDXX Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its Idexx Laboratories (IDXX) stake by 2.2% in Q2 2026, selling an estimated $189K and leaving 14,882 shares worth $7.83M. The position accounts for 0.09% of the portfolio, ranked #168.

F.L. Putnam Investment Management first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.4M in Q4 2025. 773 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • F.L. Putnam Investment Management held 14,882 shares of Idexx Laboratories worth $7.83M as of Q2 2026.
  • F.L. Putnam Investment Management sold 337 Idexx Laboratories shares in Q2 2026, an estimated $189K.
  • Idexx Laboratories made up 0.09% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #168 holding.
  • F.L. Putnam Investment Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • F.L. Putnam Investment Management's Idexx Laboratories position peaked at $10.4M in Q4 2025.
  • 773 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.